Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome .
This report has been verified
by one or more authors of the
original publication.
Botulinum toxin a does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial
J Bone Joint Surg Am. 2013 Mar 6;95(5):400-7. doi: 10.2106/JBJS.L.00889Exclusive Author Interview
Dr.Engstrom discusses the use of Botulinum toxin A with cast treatment for idiopathic toe-walking
52 children were randomized to examine whether the addition of botulinum toxin A prior to cast treatment was effective in managing idiopathic toe-walking. Patients were treated with either 4 weeks of below-the-knee casts alone or 4 weeks of cast treatment 1 to 2 weeks following botulinum toxin A injections into the calves. The assessment at 12 months revealed that botulinum toxin A injections with cast treatment did not improve any of the gait parameters when compared to cast treatment alone.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
